Abstract

Galactorrhea and amenorrhea are known risks of risperidone, given risperidone’s blockade of dopamine D2 receptors and subsequent risk of prolactin elevation, and this paper presents the case of an ...

Highlights

  • Galactorrhea and amenorrhea are known risks of risperidone, given risperidone’s blockade of dopamine D2 receptors and subsequent risk of prolactin elevation, and this paper presents the case of an adolescent female patient who developed reversible amenorrhea and galactorrhea after being treated with risperidone 0.25 mg twice a day for three months

  • Since the late 1970s it has been known that neuroleptics can raise prolactin levels due to their dopamine antagonist action (Sachar, Gruen, Altman, & Frantz, 1976)

  • This patient did not have elevated levels of prolactin, her case must be placed in the context of the available literature of risperidone’s effect on the tuberoinfundibular pathway and associated side effects

Read more

Summary

Introduction

Galactorrhea and amenorrhea are known risks of risperidone, given risperidone’s blockade of dopamine D2 receptors and subsequent risk of prolactin elevation, and this paper presents the case of an adolescent female patient who developed reversible amenorrhea and galactorrhea after being treated with risperidone 0.25 mg twice a day for three months. In this paper a case of the latter is reported, though with the unusual feature of prolactin levels remaining normal. Past treatment of these conditions included quetiapine, which had no effect, and aripiprazole, which increased the patient’s aggression.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.